. High FOXO3A expression predicts good prognosis of patients with melanoma. Relationship between FOXO3a expression, and the (A) overall survival in the database termed Tumor Melanoma Metastatic Bhardwaj-44-MAS5.0-u133p2 from the R2 platform determined using an alternative FOXO3A probe. (B-D) Relationship between FOXO3A expression and survival post-metastasis in the database termed Tumor Melanoma Metastatic Bhardwaj-44-MAS5.0-u133p2 determined using alternative probes. (E and F) Expression of FOXO3A in stage III and IV melanoma in the database termed Tumor Melanoma Metastatic Bhardwaj-44-MAS5.0-u133p2 determined using alternative FOXO3A probes.
. FOXO3a is negatively correlated with aerobic glycolysis-associated genes in melanoma cohorts. Correlation of FOXO3A expression and the expression of glycolytic genes, including (A-C) HK1/3, (D and E) PKFM, (F-I) PKM, (J and K) PFKFB3 and (L-O) LDHA in various melanoma cohorts analyzed using different probes. FOXO3A, forkhead box O3; HK1/3, hexokinase 1/3; PFKM, phosphofructokinase muscle; PKM, pyruvate kinase isozyme; PFKFB3, phosphofructokinase fructobiphosphatase 3; LDHA, lactate dehydrogenase A.
